Related Experiment Video
Updated: Mar 26, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immunomodulating Drugs Based on Poxviral Proteins.
Galina A Shchelkunova1, Sergei N Shchelkunov2,3
1State Research Center of Virology and Biotechnology VECTOR, Koltsovo, Novosibirsk region, 630559, Russia.
Investigating immune modulators from variola virus offers potential for new autoimmune disease treatments. These poxvirus proteins effectively target inflammatory mediators, addressing limitations of current therapies.
Area of Science:
- Immunology
- Virology
- Drug Discovery
Background:
- Chronic inflammatory autoimmune diseases are driven by excessive cytokine/chemokine production and complement activation.
- Current biological therapies targeting immune mediators have limitations in efficacy and adverse effects.
- Novel immunomodulatory proteins are crucial for developing improved autoimmune disease treatments.
Purpose of the Study:
- To explore the potential of poxvirus-derived immunomodulatory proteins as novel therapeutic agents for autoimmune diseases.
- To investigate the mechanisms by which variola virus proteins modulate immune responses.
Main Methods:
- Analysis of poxvirus genomes for genes encoding immunomodulatory proteins.
- Biochemical characterization of identified viral proteins and their interactions with host immune components (cytokines, chemokines, complement).
- In silico and in vitro studies to assess the efficacy of these proteins in modulating inflammatory pathways.
Main Results:
- Variola virus encodes highly evolved immunomodulatory proteins with potent binding capabilities for cytokines, chemokines, and complement system proteins.
- These viral proteins demonstrate significant potential to counteract key drivers of chronic inflammation.
Conclusions:
- Variola virus immunomodulators represent a promising source for developing new drugs against autoimmune diseases.
- Further research into these viral proteins could lead to more effective and targeted therapies, overcoming current treatment challenges.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cell-mediated Immune Responses

